Provided by Tiger Trade Technology Pte. Ltd.

Celcuity Inc

137.68
+2.962.20%
Pre-market: 136.51-1.1700-0.85%06:59 EDT
Volume:1.48M
Turnover:200.40M
Market Cap:6.65B
PE:-35.41
High:139.63
Open:130.20
Low:126.43
Close:134.72
52wk High:151.02
52wk Low:10.26
Shares:48.34M
Float Shares:29.65M
Volume Ratio:1.16
T/O Rate:4.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8880
EPS(LYR):-3.7900
ROE:-275.17%
ROA:-37.12%
PB:124.33
PE(LYR):-36.33

Loading ...

Company Profile

Company Name:
Celcuity Inc
Exchange:
NASDAQ
Establishment Date:
2011
Employees:
155
Office Location:
16305 36th Avenue North,Suite 100,Minneapolis,Minnesota,United States
Zip Code:
55446
Fax:
- -
Introduction:
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Directors

Name
Position
Brian F. Sullivan
Chairman of the Board and Chief Executive Officer
Lance G. Laing
Chief Science Officer, Vice President , Secretary and Director
Charles R. Romp
Director
David F. Dalvey
Director
Leo T. Furcht
Director
Polly A. Murphy
Director
Richard E. Buller
Director
Richard J. Nigon
Director

Shareholders

Name
Position
Brian F. Sullivan
Chairman of the Board and Chief Executive Officer
Vicky Hahne
Chief Financial Officer
Lance G. Laing
Chief Science Officer, Vice President , Secretary and Director